Literature DB >> 6683289

Binding capacity of testosterone-estradiol-binding globulin (TeBG), total and calculated unbound concentrations of testosterone in patients with carcinoma of the prostate treated with orchidectomy or estrogens.

J E Damber, B Bergman, R Södergård, R Tomić.   

Abstract

Testosterone-estradiol-binding globulin (TeBG) binding capacity, total estradiol-17 beta and total testosterone were measured in patients with carcinoma of the prostate treated with orchidectomy or estrogens. Comparisons were made with a control group. There was a significant increase in TeBG binding capacity in the group treated with estrogens. Both orchidectomy and estrogen-treatment decreased total testosterone significantly and to the same degree. The concentration of free testosterone was calculated using a new method, and was found to be lower in orchidectomized and estrogen treated patients when compared with the control group. When the two groups under treatment were compared, the calculated free testosterone concentration was significantly lower in the estrogen treated group.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6683289     DOI: 10.1007/BF03350578

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  20 in total

1.  A paper chromatographic saturation analysis method for measuring estradiol, testosterone and 5alpha-dihydrotestosterone from the same sample.

Authors:  H Carstensen; T Bäckström
Journal:  J Steroid Biochem       Date:  1976-02       Impact factor: 4.292

2.  Sex-hormone-binding globulin is an oestrogen amplifier.

Authors:  C W Burke; D C Anderson
Journal:  Nature       Date:  1972-11-03       Impact factor: 49.962

3.  A new method for the determination of the binding capacity of testosterone-estradiol-binding-globulin in human plasma.

Authors:  V P Shanbhag; R Södergård; H Carstensen; P A Albertsson
Journal:  J Steroid Biochem       Date:  1973-09       Impact factor: 4.292

4.  The influence of serum on uptake, conversion and action of testosterone in rat prostate glands in organ culture.

Authors:  I Lasnitzki; H R Franklin
Journal:  J Endocrinol       Date:  1972-08       Impact factor: 4.286

5.  Assay of ethynyloestradiol in human serum and its binding to plasma proteins.

Authors:  J Akpoviroro; K Fotherby
Journal:  J Steroid Biochem       Date:  1980-07       Impact factor: 4.292

6.  Sex hormone binding globulin binding capacity, testosterone, 5alpha-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormonal treatment.

Authors:  W Bartsch; H J Horst; H Becker; G Nehse
Journal:  Acta Endocrinol (Copenh)       Date:  1977-07

7.  Serum sex hormone binding globulin and testosterone binding after estradiol administration, castration, and their combination in men with prostatic carcinoma.

Authors:  P Leinonen; G L Hammond; O Lukkarinen; R Vihko
Journal:  Invest Urol       Date:  1979-07

8.  Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.

Authors:  J P Karr; Z Wajsman; R Y Kirdani; G P Murphy; A A Sandberg
Journal:  J Urol       Date:  1980-08       Impact factor: 7.450

9.  Sex hormone binding globulin: the carrier protein for d-norgestrel.

Authors:  A Victor; E Weiner; E D Johansson
Journal:  J Clin Endocrinol Metab       Date:  1976-07       Impact factor: 5.958

10.  Effect of hormonal therapy on plasma testosterone levels in prostatic carcinoma.

Authors:  M R Robinson; B S Thomas
Journal:  Br Med J       Date:  1971-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.